Streetbeat News

Partnerships

SFTBF

SYM

SoftBank Group Corp. and Symbotic Inc. have announced the establishment of a joint venture, GreenBox Systems LLC, to address the $5001 billion annual warehouse-as-a-service market. Symbotic also announced a $7.5 billion new customer contract with GreenBox, who will be the exclusive provider of Symbotic systems in the warehouse-as-a-service market. Symbotic expects over $500 million in annual recurring revenue from GreenBox once all systems are operational.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:07 am

IGT

IGT has signed a multi-year agreement with the St. Croix Chippewa Indians of Wisconsin to expand its sports betting footprint in the state. The deal will see IGT's PlaySports technology powering sports betting at St. Croix Casinos.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:48 am

IMGN

ImmunoBiochem has entered into a multi-target license and option agreement with ImmunoGen. As part of the agreement, ImmunoGen will pay ImmunoBiochem an upfront fee for an exclusive license to existing antibodies. ImmunoBiochem will be eligible to receive milestone payments and royalties based on the achievement of pre-specified development, regulatory, and commercial milestones.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:35 am

SSNLF

STLA

Stellantis NV (NYSE:STLA) and Samsung SDI have signed a memorandum of understanding to build a second battery manufacturing facility in the U.S. The companies aim to start production in 2027 with an initial annual production capacity of 34 GWh. The new facility is part of the StarPlus Energy joint venture created in May 2022, which had a planned investment of over $2.5 billion.

Portfolio Pulse from Lekha Gupta

July 24, 2023 | 9:55 am

PFE

SYRS

Syros Pharmaceuticals received a notice from Pfizer, which has succeeded Global Blood Therapeutics, to terminate an agreement related to Sickle Cell Disease and Beta-thalassemia therapies. The termination will be effective from October 16, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 9:20 am

AZN

Amoy Diagnostics has signed a cooperation agreement with Kudos Pharmaceuticals, a unit of AstraZeneca UK, on HRD test product.

Portfolio Pulse from Charles Gross

July 24, 2023 | 9:01 am

TSLA

Elon Musk, CEO of Tesla, expressed surprise at the general public's lack of awareness about Tesla's Full Self-Driving (FSD) technology. This comes after Tesla's recent announcements about the future of its FSD technology, including a one-off amnesty for customers to transfer their FSD software to a new vehicle and the upcoming release of FSD version 12. Tesla is also in early discussions to license its self-driving technology to a major automaker.

Portfolio Pulse from Benzinga Neuro

July 24, 2023 | 6:00 am

ALNY

RHHBY

Alnylam Pharmaceuticals has partnered with Roche to develop and commercialize Zilebesiran, Alnylam's investigational RNAi therapeutic for hypertension treatment. Alnylam will receive an upfront cash payment of $310 million and is eligible for development, regulatory, and sales milestones, potentially valuing the deal at up to $2.8 billion. The companies will share profits and losses equally in the US, and Alnylam will receive royalties on net sales outside the US.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 5:53 am

STLA

Stellantis and Samsung SDI have announced plans to build a second StarPlus Energy Gigafactory in the US, with an initial annual production capacity of 34 GWh.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 5:46 am

EXEL

TEVA

Exelixis has entered into a settlement and license agreement for CABOMETYX patent litigation with Teva Pharmaceuticals Development and Teva Pharmaceuticals USA.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 5:21 am